458 related articles for article (PubMed ID: 33412828)
21. Geographical and socioeconomic differences in uptake of Pap test and mammography in Italy: results from the National Health Interview Survey.
Petrelli A; Giorgi Rossi P; Francovich L; Giordani B; Di Napoli A; Zappa M; Mirisola C; Gargiulo L
BMJ Open; 2018 Sep; 8(9):e021653. PubMed ID: 30232106
[TBL] [Abstract][Full Text] [Related]
22. Patient Navigation for Comprehensive Cancer Screening in High-Risk Patients Using a Population-Based Health Information Technology System: A Randomized Clinical Trial.
Percac-Lima S; Ashburner JM; Zai AH; Chang Y; Oo SA; Guimaraes E; Atlas SJ
JAMA Intern Med; 2016 Jul; 176(7):930-7. PubMed ID: 27273602
[TBL] [Abstract][Full Text] [Related]
23. Population-level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures.
Nyante SJ; Benefield TS; Kuzmiak CM; Earnhardt K; Pritchard M; Henderson LM
Cancer; 2021 Jun; 127(12):2111-2121. PubMed ID: 33635541
[TBL] [Abstract][Full Text] [Related]
24. The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea.
Park H; Seo SH; Park JH; Yoo SH; Keam B; Shin A
Epidemiol Health; 2022; 44():e2022053. PubMed ID: 35760396
[TBL] [Abstract][Full Text] [Related]
25. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.
Chen RC; Haynes K; Du S; Barron J; Katz AJ
JAMA Oncol; 2021 Jun; 7(6):878-884. PubMed ID: 33914015
[TBL] [Abstract][Full Text] [Related]
26. Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium.
Tosteson AN; Beaber EF; Tiro J; Kim J; McCarthy AM; Quinn VP; Doria-Rose VP; Wheeler CM; Barlow WE; Bronson M; Garcia M; Corley DA; Haas JS; Halm EA; Kamineni A; Rutter CM; Tosteson TD; Trentham-Dietz A; Weaver DL;
J Gen Intern Med; 2016 Apr; 31(4):372-9. PubMed ID: 26658934
[TBL] [Abstract][Full Text] [Related]
27. Time trends of process and impact indicators in Italian breast screening programmes--1996-2005.
Giordano L; Giorgi D; Piccini P; Ventura L; Stefanini V; Senore C; Paci E; Segnan N
Epidemiol Prev; 2008; 32(2 Suppl 1):23-36. PubMed ID: 18770993
[TBL] [Abstract][Full Text] [Related]
28. Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium.
Barlow WE; Beaber EF; Geller BM; Kamineni A; Zheng Y; Haas JS; Chao CR; Rutter CM; Zauber AG; Sprague BL; Halm EA; Weaver DL; Chubak J; Doria-Rose VP; Kobrin S; Onega T; Quinn VP; Schapira MM; Tosteson ANA; Corley DA; Skinner CS; Schnall MD; Armstrong K; Wheeler CM; Silverberg MJ; Balasubramanian BA; Doubeni CA; McLerran D; Tiro JA
J Natl Cancer Inst; 2020 Mar; 112(3):238-246. PubMed ID: 31292633
[TBL] [Abstract][Full Text] [Related]
29. [Introduction of a centralised system (Service) for collecting clinical data in cancer screening programmes in Piedmont (Northern Italy): a pre-post assessment of a hub&spoke model].
Gallo F; Giubilato P; Larato C; Caprioglio A; Tomatis M; Calcagno M; Casella D; Di Leo A; Ponti A; Ronco G; Segnan N; Giordano L;
Epidemiol Prev; 2015; 39(4):243-50. PubMed ID: 26499237
[TBL] [Abstract][Full Text] [Related]
30. [Mammography breast cancer screening in Italy: 2010 survey].
Giorgi D; Giordano L; Ventura L; Frigerio A; Paci E; Zappa M
Epidemiol Prev; 2012; 36(6 Suppl 1):8-27. PubMed ID: 23293268
[TBL] [Abstract][Full Text] [Related]
31. Breast, Cervical, and Colorectal Cancer Screening Adherence: Effect of Low Body Mass Index in Women.
Charkhchi P; Schabath MB; Carlos RC
J Womens Health (Larchmt); 2020 Jul; 29(7):996-1006. PubMed ID: 31928405
[No Abstract] [Full Text] [Related]
32. Effects of cancer screening restart strategies after COVID-19 disruption.
Kregting LM; Kaljouw S; de Jonge L; Jansen EEL; Peterse EFP; Heijnsdijk EAM; van Ravesteyn NT; Lansdorp-Vogelaar I; de Kok IMCM
Br J Cancer; 2021 Apr; 124(9):1516-1523. PubMed ID: 33723386
[TBL] [Abstract][Full Text] [Related]
33. Impact of SARS-CoV-2 Pandemic on Colorectal Cancer Screening Delay: Effect on Stage Shift and Increased Mortality.
Ricciardiello L; Ferrari C; Cameletti M; Gaianill F; Buttitta F; Bazzoli F; Luigi de'Angelis G; Malesci A; Laghi L
Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1410-1417.e9. PubMed ID: 32898707
[TBL] [Abstract][Full Text] [Related]
34. Japanese cancer screening programs during the COVID-19 pandemic: Changes in participation between 2017-2020.
Machii R; Takahashi H
Cancer Epidemiol; 2023 Feb; 82():102313. PubMed ID: 36508964
[TBL] [Abstract][Full Text] [Related]
35. BRCA testing delay during the COVID-19 pandemic: How to act?
Minucci A; Scambia G; De Bonis M; De Paolis E; Santonocito C; Fagotti A; Capoluongo E; Concolino P; Urbani A
Mol Biol Rep; 2021 Jan; 48(1):983-987. PubMed ID: 33313973
[TBL] [Abstract][Full Text] [Related]
36. Association of an Active Choice Intervention in the Electronic Health Record Directed to Medical Assistants With Clinician Ordering and Patient Completion of Breast and Colorectal Cancer Screening Tests.
Hsiang EY; Mehta SJ; Small DS; Rareshide CAL; Snider CK; Day SC; Patel MS
JAMA Netw Open; 2019 Nov; 2(11):e1915619. PubMed ID: 31730186
[TBL] [Abstract][Full Text] [Related]
37. Effects of the COVID-19 pandemic on breast cancer screening in Taiwan.
Tsai HY; Chang YL; Shen CT; Chung WS; Tsai HJ; Chen FM
Breast; 2020 Dec; 54():52-55. PubMed ID: 32919172
[TBL] [Abstract][Full Text] [Related]
38. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
39. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
40. Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women.
Bertaut A; Coudert J; Bengrine L; Dancourt V; Binquet C; Douvier S
PLoS One; 2018; 13(6):e0198939. PubMed ID: 29927995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
